RNA

Avidity Biosciences (RNA)

Avidity Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RNA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/17	06 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/12/14	08 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/12/12	06 : 59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/11/27	00 : 00	PR Newswire (US)	Avidity Biosciences to Participate in Upcoming Investor Conference	NASDAQ:RNA	Avidity Biosciences Inc
2024/11/22	06 : 05	PR Newswire (US)	Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RNA	Avidity Biosciences Inc
2024/11/21	08 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/11/14	23 : 39	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:RNA	Avidity Biosciences Inc
2024/11/14	06 : 40	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:RNA	Avidity Biosciences Inc
2024/11/12	21 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNA	Avidity Biosciences Inc
2024/11/12	21 : 00	PR Newswire (US)	Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations	NASDAQ:RNA	Avidity Biosciences Inc
2024/11/08	06 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNA	Avidity Biosciences Inc
2024/11/08	06 : 05	PR Newswire (US)	Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights	NASDAQ:RNA	Avidity Biosciences Inc
2024/10/31	22 : 00	PR Newswire (US)	Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024	NASDAQ:RNA	Avidity Biosciences Inc
2024/10/30	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNA	Avidity Biosciences Inc
2024/10/30	21 : 00	PR Newswire (US)	Avidity Biosciences Pursues Potential Accelerated Approval Path with Initiation of Biomarker Cohort in FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax/AOC 1020) in People Living with Facioscapulohumeral Muscular Dystrophy	NASDAQ:RNA	Avidity Biosciences Inc
2024/10/22	05 : 05	PR Newswire (US)	Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RNA	Avidity Biosciences Inc
2024/10/18	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/10/10	06 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/10/04	05 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/10/03	20 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNA	Avidity Biosciences Inc
2024/10/03	20 : 00	PR Newswire (US)	Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)	NASDAQ:RNA	Avidity Biosciences Inc
2024/10/02	05 : 36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/09/25	22 : 00	PR Newswire (US)	Avidity Biosciences to Participate in Upcoming Investor Conference	NASDAQ:RNA	Avidity Biosciences Inc
2024/09/24	10 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/09/24	10 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/09/24	10 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/09/24	05 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/09/24	05 : 05	PR Newswire (US)	Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RNA	Avidity Biosciences Inc
2024/09/14	05 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/09/14	05 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc